[{"Assets_0_Q3_USD":10521662000.0,"CommonStockSharesOutstanding_0_Q3_shares":224288553.0,"EarningsPerShareBasic_1_Q3_USD":-0.77,"EarningsPerShareBasic_3_Q3_USD":-3.3,"EarningsPerShareDiluted_1_Q3_USD":-0.77,"EarningsPerShareDiluted_3_Q3_USD":-3.3,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":196992000.0,"NetIncomeLoss_1_Q3_USD":-173205000.0,"NetIncomeLoss_3_Q3_USD":-739561000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":224132000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":223829000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":224132000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":223829000.0,"Ticker":"ENDP","CIK":"1593034","name":"ENDO INTERNATIONAL PLC","OfficialName":"Endo International plc Ordinary Shares","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"640358301.0","Country":"Ireland","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181108"}]